190 related articles for article (PubMed ID: 11733495)
21. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1.
Haruta T; Uno T; Kawahara J; Takano A; Egawa K; Sharma PM; Olefsky JM; Kobayashi M
Mol Endocrinol; 2000 Jun; 14(6):783-94. PubMed ID: 10847581
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RAR gamma degradation and transactivation.
Giannì M; Bauer A; Garattini E; Chambon P; Rochette-Egly C
EMBO J; 2002 Jul; 21(14):3760-9. PubMed ID: 12110588
[TBL] [Abstract][Full Text] [Related]
23. The Nuclear Export and Ubiquitin-Proteasome-Dependent Degradation of PPARγ Induced By Angiotensin II.
Sun L; Bian K
Int J Biol Sci; 2019; 15(6):1215-1224. PubMed ID: 31223281
[TBL] [Abstract][Full Text] [Related]
24. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes.
Boudjelal M; Wang Z; Voorhees JJ; Fisher GJ
Cancer Res; 2000 Apr; 60(8):2247-52. PubMed ID: 10786691
[TBL] [Abstract][Full Text] [Related]
25. c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity.
Camp HS; Tafuri SR; Leff T
Endocrinology; 1999 Jan; 140(1):392-7. PubMed ID: 9886850
[TBL] [Abstract][Full Text] [Related]
26. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway.
Schubert U; Antón LC; Bacík I; Cox JH; Bour S; Bennink JR; Orlowski M; Strebel K; Yewdell JW
J Virol; 1998 Mar; 72(3):2280-8. PubMed ID: 9499087
[TBL] [Abstract][Full Text] [Related]
27. The co-repressor hairless protects RORalpha orphan nuclear receptor from proteasome-mediated degradation.
Moraitis AN; Giguère V
J Biol Chem; 2003 Dec; 278(52):52511-8. PubMed ID: 14570920
[TBL] [Abstract][Full Text] [Related]
28. The ubiquitin-proteasome pathway.
Roos-Mattjus P; Sistonen L
Ann Med; 2004; 36(4):285-95. PubMed ID: 15224655
[TBL] [Abstract][Full Text] [Related]
29. Interferon gamma enhances proteasome activity in recombinant Hep G2 cells that express cytochrome P4502E1: modulation by ethanol.
Osna NA; Clemens DL; Donohue TM
Biochem Pharmacol; 2003 Sep; 66(5):697-710. PubMed ID: 12948850
[TBL] [Abstract][Full Text] [Related]
30. The hinge-helix 1 region of peroxisome proliferator-activated receptor gamma1 (PPARgamma1) mediates interaction with extracellular signal-regulated kinase 5 and PPARgamma1 transcriptional activation: involvement in flow-induced PPARgamma activation in endothelial cells.
Akaike M; Che W; Marmarosh NL; Ohta S; Osawa M; Ding B; Berk BC; Yan C; Abe J
Mol Cell Biol; 2004 Oct; 24(19):8691-704. PubMed ID: 15367687
[TBL] [Abstract][Full Text] [Related]
31. Direct demonstration of rapid degradation of nuclear sterol regulatory element-binding proteins by the ubiquitin-proteasome pathway.
Hirano Y; Yoshida M; Shimizu M; Sato R
J Biol Chem; 2001 Sep; 276(39):36431-7. PubMed ID: 11477106
[TBL] [Abstract][Full Text] [Related]
32. Cell adhesion protects c-Raf-1 against ubiquitin-dependent degradation by the proteasome.
Manenti S; Delmas C; Darbon JM
Biochem Biophys Res Commun; 2002 Jun; 294(5):976-80. PubMed ID: 12074572
[TBL] [Abstract][Full Text] [Related]
33. Troglitazone induces G1 arrest by p27(Kip1) induction that is mediated by inhibition of proteasome in human gastric cancer cells.
Takeuchi S; Okumura T; Motomura W; Nagamine M; Takahashi N; Kohgo Y
Jpn J Cancer Res; 2002 Jul; 93(7):774-82. PubMed ID: 12149143
[TBL] [Abstract][Full Text] [Related]
34. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway.
Kim TK; Maniatis T
Science; 1996 Sep; 273(5282):1717-9. PubMed ID: 8781235
[TBL] [Abstract][Full Text] [Related]
35. Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation.
Lipford JR; Deshaies RJ
Nat Cell Biol; 2003 Oct; 5(10):845-50. PubMed ID: 14523392
[TBL] [Abstract][Full Text] [Related]
36. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma ) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes.
Prusty D; Park BH; Davis KE; Farmer SR
J Biol Chem; 2002 Nov; 277(48):46226-32. PubMed ID: 12270934
[TBL] [Abstract][Full Text] [Related]
37. Caspase-activated PAK-2 is regulated by subcellular targeting and proteasomal degradation.
Jakobi R; McCarthy CC; Koeppel MA; Stringer DK
J Biol Chem; 2003 Oct; 278(40):38675-85. PubMed ID: 12853446
[TBL] [Abstract][Full Text] [Related]
38. The nuclear ubiquitin-proteasome system degrades MyoD.
Floyd ZE; Trausch-Azar JS; Reinstein E; Ciechanover A; Schwartz AL
J Biol Chem; 2001 Jun; 276(25):22468-75. PubMed ID: 11309375
[TBL] [Abstract][Full Text] [Related]
39. Ubiquitin-dependent degradation of Id1 and Id3 is mediated by the COP9 signalosome.
Berse M; Bounpheng M; Huang X; Christy B; Pollmann C; Dubiel W
J Mol Biol; 2004 Oct; 343(2):361-70. PubMed ID: 15451666
[TBL] [Abstract][Full Text] [Related]
40. 3-phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation.
Yin Y; Yuan H; Wang C; Pattabiraman N; Rao M; Pestell RG; Glazer RI
Mol Endocrinol; 2006 Feb; 20(2):268-78. PubMed ID: 16150867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
